Vong Medical
Transcatheter Mitral and Tricuspid Heart Valves
Company Overview
Snapshot
Founded in January 2018 by Ofer Bogomoletz, Vong Medical operates with 1–10 employees and is currently in the Pre-Funding stage. The company is focused on developing advanced transcatheter heart valves for mitral and tricuspid conditions.
Business overview
Vong Medical is a medical device company specializing in the development of transcatheter mitral and tricuspid heart valves. Its core technology focuses on creating ultra low-profile catheter-based valves designed to adapt to various heart sizes, including the large dimensions of the mitral and tricuspid annuluses. The company aims to improve patient survival rates by serving the healthcare market, particularly in cardiology and medical treatment, and operates within the Health Tech & Life Sciences sector.
Log in to access full profile ›Company Intelligence Q&A
- What is Vong Medical's primary focus?
- Vong Medical is focused on developing transcatheter mitral and tricuspid heart valves designed to improve patient survival rates by adapting to various heart sizes and utilizing an ultra low-profile catheter.
- When was Vong Medical founded?
- Vong Medical was founded in January 2018.
- Who is the founder of Vong Medical?
- Ofer Bogomoletz is the Founder & CEO of Vong Medical.
- What stage is Vong Medical currently in?
- Vong Medical is currently in the Pre-Funding stage, with its product development in the R&D phase.
- What markets does Vong Medical target?
- Vong Medical targets the healthcare market, specifically focusing on providers within the cardiology and heart disease treatment segments, with a B2C business model.